Catalyst Pharmaceuticals to Participate in the BofA Securities Health Care Conference 2025

Core Points - Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing novel medicines for patients with rare diseases [1][3] - The company will participate in the BofA Securities Health Care Conference 2025 on May 14, 2025, in Las Vegas, Nevada [1][2] - Catalyst has been recognized on the Forbes 2025 list as one of America's Most Successful Mid-Cap Companies and on the 2024 Deloitte Technology Fast 500™ list as one of North America's Fastest-Growing Companies [3] Presentation Details - The presentation will take place on May 14, 2025, at 8:00 am PT [2] - A webcast of the presentation will be available on the company's website, with a replay accessible for at least 14 days [2] Company Overview - Catalyst Pharmaceuticals is committed to improving the lives of patients with rare diseases through innovative therapies and a comprehensive suite of support services [3] - The company maintains a strong U.S. presence and is actively seeking to expand its global commercial footprint through strategic partnerships [3]